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Patients after an ACS have a higher risk of anxio-depressive symptoms
compared with other. Association between the two diseases is complex,
involving among other, pro-inflammatory markers, neuro-hormones and the
sympathetic system. Patients with high HADS score more often have
unhealthy lifestyle which predict worse outcome and complicate their care.
Anxio-depressive symptoms are common after an ACS, but often underdi-
agnosed. It is essential to train the cardiology team to early identify at risk
patients, so to offer them appropriate care. 
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Purpose: Despite significant enhancements in resuscitation methodology,
survival after sudden cardiac arrest remains low. Improved knowledge of
warning signs and symptoms may help to detect victims for sudden death.
Aim: to study the warning symptoms prior to sudden cardiac death.
Methods: We prospectively collected epidemiological and autopsy data
from victims of sudden cardiac death in northern Tunisia (3.6 million people)
between October 2012 and September 2013. We included victims ≥20 years
old requiring a forensic autopsy. 
Data (risk factors, symptoms) were collected by assessment of the accounts
of family members/relatives, witnesses, as well as medical records during this
time period. 
The heart was weighed and then investigated by macroscopic examination
looking for scars of myocardial infarction. The three main coronary arteries
were macroscopically examined by transverse slices at 2-3-mm intervals along
their lengths.
Results: Of the 542 sudden deaths within the study period, 372 males and
91 females were medico-legally autopsied. Mean age of victims was 50.9±15
years. Physical inactivity and smoking were the most common risk factors,
accounting for 74.7% and 61.5%, respectively. A family history of sudden
death was identified in 10.8% of victims. Most deaths occurred in a public
place (39.3%) or at home (36.9%).
Of the total deaths, 298 (64.4%) occurred while the individuals were
relaxing, 52 (11.2%) while sleeping, 92 (19.9%) while dealing with an
activity, and 21 (4.5%) under emotional stress.
Syncope was the most frequent symptom occurring in 36.1%, chest pain in
18.6%, dyspnea in 8.6% and 10.1% had dizziness or fainting.
The autopsic study showed that 231 deaths (49.9%) were due to coronary
artery diseases. Eight percent of victims have consulted a doctor within the
last 48 hours and 21% up to 1 month. 
Conclusions: Warning symptoms prior to sudden cardiac death may occur
longer before the death. Recognizing these precocious signs could have impli-
cations for prevention of this public health problem. 
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Background: Recommendations for healthy food choice emphasize the
consumption of 2 to 3 servings of dairy products per day. We aimed to
describe dietary patterns and adherence to recommendations according to the
consumption of different types of dairy products.
Methods: Data from the 2010 CCAF (Comportements et Consommations
Alimentaires en France) cross-sectional survey with 7-day food record were
analysed. Fresh Dairy Products (FDP) included all fresh dairy except dairy
desserts and Greek yogurts. Cheese included all cheese except cottage cheese.
The PANdiet (Probability of Adequate Nutrient intake) score was used to
assess adherence to dietary recommendations. 
Results: The sample comprised 948 French adults from the general popu-
lation, 22% consumed no FDP and 30% were low FDP consumers (1 to 3
servings/week), 9% consumed no cheese and 37% were low cheese consumers
(1 serving/day). Compared to low consumers, high FDP and cheese consumers
were characterized by significantly (p<0.05) higher intakes of fruits and
vegetables. High FDP consumers also exhibited significantly higher intakes of
simple sugars (+25%) than low FDP consumers, and significantly lower
intakes of pastas (–27%), ready-to-eat meals (–16%), and alcoholic beverages
(–22%). No significant difference was observed for daily energy intake, total
fat, saturated fat, or sodium. On the other hand, high cheese consumers exhi-
bited significantly higher daily energy intake (+23%) and higher consumptions
of alcohol (+96%), total fat (+31%), saturated fat (+41%) and sodium (+36%),
compared to low consumers, with no difference for simple sugar intake. The
PANdiet score was significantly better among high FDP consumers than
among low, but significantly worse among high cheese consumers than among
low.
Conclusion: Consumers of FDP and consumers of cheese adopt different
dietary patterns with varying intakes of sugars, fats, and sodium. Adherence
to dietary recommendations is better among high FDP consumers. 
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Background: Quality of life (QoL) and burden scales have proved to be
useful in estimating the impact of diseases and treatments from the patient’s
perspective. Yet, no data nor scales are currently available with respect to the
burden associated with the low sodium diet usually prescribed in heart failure
(HF) patients, despite the lack of evidence of its efficacy and the previously
reported evidence for negative effects in restricted diets (e.g. gluten-free).
Objectives: To develop and validate a low sodium diet burden scale in HF
patients.
Methods: After a literature review and interviews with patients, 14 items
were selected (coded 0-4, global score/70, higher scores reflecting higher
burden) for the following domains relating to dietary habits: organization,
pleasure, leisure, social life, vitality and self-rated health. The validation study
was conducted in HF patients (NYHA I-IV) prospectively enrolled between
09/2012-09/2013 (H.Mondor Hospital, Cardiology Dpt, Creteil).
Results: 93 patients completed the burden scale (men 64%; mean age 63.2
[±13.3]), of whom 14% had a highly restricted low sodium diet (<3g/d), 37%
moderately restricted (3-6g) and 49% mildly restricted. Median burden score
was 9 (IQR 3-17; min 0-max 40); results showed an excellent acceptability of
the scale (non response rates/item: 2% to 12%), excellent internal consistency
(Cronbach α=0.90; Spearman correlation coefficients between items and
global score: rs from 0.47 [appetite] to 0.81 [mental burden]; p<0.001), good
convergent validity (positive correlation between the global burden score and
dimensions scores from the QoL Minnesota scale: rs=0.49 [physical dimen-
sion], 0.57 [mental], 0.52 [global]; p<0.001) and good discriminative capacity
of the patients with a highly restricted diet (p=0.01; Figure next page).
Conclusion: These first findings demonstrate the good psychometric pro-
perties of a new burden scale and show that highly restricted salt diet is asso-
ciated with high burden in HF patients. 
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Background: Patient adherence is an essential factor in obtaining an effi-
cient oral anticoagulation using antivitamin K drugs (AVK), a situation with
a narrow therapeutic window. Therefore patient education and awareness are
crucial for a good management and should be based on a correct estimation of
the current situation.
Material and methods: This study included 67 hospitalized chronically
anticoagulated patients (pts) (mean age: 62.6±13.1 years; men 45.6%) who
responded to a 25-items questionnaire to assess their knowledge on AVK
therapy management. Laboratory and clinical data were used to determine
INR value at admission, as well as to calculate CHADS2-VASC and HAS-
BLED scores for patients with atrial fibrillation (AF).
Results: The majority of pts (61.8%) were receiving AVK for AF, the
others having a mechanical prosthesis and previous thromboembolic dis-
ease or stroke. In the AF group, mean CHADS2-VASC score was 3.1±1.5,
while average HAS-BLED score was 1.8±1.2. More than half of all pts
(52.9%) had at admission an INR outside of the therapeutic range, with the
majority (42.1%) having a low INR. A correct INR value was predicted by
the education level (higher education), the diagnostic indication (pts with
mechanical prosthesis being best managed), and the concomitant use of
other antithrombotic therapies. Pts presenting with a therapeutic INR had
a trend towards longer treatment duration than those outside the thera-
peutic range (62±72 vs 36±35 months, p=0.06). There was no correlation
between admission INR and pts living conditions, INR monitoring fre-
quency, bleeding history. 
Conclusions: In a tertiary cardiology center, more than half pts receiving
AVK are admitted with an INR outside the therapeutic range. Pts with
mechanic prosthesis and complex antithrombotic regimens appear as most
careful with INR monitoring. Identifying pts groups with lowest therapeutic
range rate could help attending physicians educate pts focusing on specific
awareness issues. 
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Purpose: The CHA2DS2-VASc score has been validated to stratify the risk
of thromboembolism and accurately predicts the risk of stroke in patient with
non-valvular atrial fibrillation. We sought to investigate how accurately this
score predicts the risk of stroke and death in patients with atrial flutter. 
Methods: Between July 1998 and December 2011, 197 consecutive
patients, hospitalised for atrial flutter, were enrolled in the cohort. All patients
were followed-up at least 6 months and cardiovascular events recorded. The
endpoint was defined as the first occurrence of stroke or death. The Cox anal-
ysis was adjusted on warfarin, antiplatelet and antiarrhythmic treatments at
discharge. 
Results: Mean age was 67±13 years and 152 (77%) were men. At baseline,
92 patients (47%) had hypertension, 33 (17%) diabetes, and 10 (5%) had a
history of stroke or thromboembolism. CHA2DS2-VASc score was = 0 in 26
(13%), = 1 in 36 (18%), and ≥2 in 135 (69%) patients. Seventy-seven events
occurred during a mean follow-up of 4.7±3.7 years. As shown in the Kaplan
Meier curves (figure) patients with a CHA2DS2-VASc score ≥2 were at higher
risk of stroke or death.
The adjusted Cox model showed that a CHA2DS2-VASc score ≥2 was a
predictor of risk of stroke or death with a hazard ratio of 2.17 (95%CI 1.21-
3.90, p=0.009). 
Conclusion: These results suggest that a CHA2DS2-VASc score ≥2 is asso-
ciated with a higher risk of stroke and deaths, at mid-term follow-up, in
patients with atrial flutter.
Abstract 0396 – Figure: Burden score according to strength of restriction
Abstract 0579 – Figure: Kaplan-Meier survival curves
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